Skip to main content

Peer Review reports

From: Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia

Original Submission
28 Oct 2016 Submitted Original manuscript
3 Nov 2016 Author responded Author comments - Dominic Pilon
Resubmission - Version 2
3 Nov 2016 Submitted Manuscript version 2
11 Nov 2016 Author responded Author comments - Dominic Pilon
Resubmission - Version 3
11 Nov 2016 Submitted Manuscript version 3
5 Feb 2017 Reviewed Reviewer Report - Piyameth Dilokthornsakul
12 Feb 2017 Reviewed Reviewer Report - Elizabeth Camacho
17 Feb 2017 Reviewed Reviewer Report - Christopher Sampson
31 Mar 2017 Author responded Author comments - Dominic Pilon
Resubmission - Version 4
31 Mar 2017 Submitted Manuscript version 4
3 Apr 2017 Reviewed Reviewer Report - Elizabeth Camacho
18 Apr 2017 Reviewed Reviewer Report - Christopher Sampson
11 May 2017 Author responded Author comments - Dominic Pilon
Resubmission - Version 5
11 May 2017 Submitted Manuscript version 5
Publishing
17 May 2017 Editorially accepted
2 Jun 2017 Article published 10.1186/s12888-017-1358-3

You can find further information about peer review here.

Back to article page